Clinical trial · Interventional
Step by Step: A Tailored Walking Intervention for Breast Cancer Survivors
Feasibility of a Technology-based Intervention to Reach Inactive Breast Cancer Survivors and Objectively Track Step Activity.
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to recruit post-treatment breast cancer survivors for a 12-week 2-arm randomized walking intervention. All intervention materials will be delivered electronically. The investigators hypothesize that at the end of 12-weeks, participants randomized to the intervention group will engage in more weekly steps than those participants randomized to the comparison group.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Neoplasms | Breast Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Sedentary Lifestyle | — | UNRESOLVED | — |
| Survival Rate (Survivorship) | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Tailored Email | Behavioral | — | UNRESOLVED |
| Targeted Email | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Tailored Group
- interventionNames
- Behavioral: Tailored Email
- type
- ACTIVE_COMPARATOR
- label
- Targeted Group
- interventionNames
- Behavioral: Targeted Email
Primary outcomes (1)
- measure
- Difference in weekly steps between intervention and comparison group at the end of the intervention (week 12).
- timeFrame
- 12 weeks
- description
- The primary outcome will be measured using weekly step data as measured by a commercially available accelerometer. The primary outcome will be the difference in weekly steps between the intervention and comparison group at the end of the intervention (week 12).
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 40 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Female * 40-70 years of age * History of breast cancer stage I-II * 2-10 years post-treatment * Sedentary * Technology access and skills * Regular access to personal computer/ broadband internet and email account * Comfortability using internet, and web-based tools * US Resident Exclusion Criteria: * Concurrent enrollment in another physical activity/ lifestyle/ weight loss intervention program/study * Current secondary cancer diagnosis/ treatment * Inability to ambulate * Refusal to wear personal activity monitor (FitBit Ultra) for the duration of the study * Engaging in regular moderate to vigorous physical activity
References
Publications (0)
Data not yet available